Rifabutin (Mycobutin) and Ketamine Therapy | Tovani Health
Mycobutin (Rifabutin) — Rifamycin antimycobacterial (TB + HIV co-infection)
Verdict at Tovani Health
CYP3A4 inducer (~40% as potent as rifampin); plan around the course.
Rifabutin alongside ketamine requires individual evaluation. Rifabutin is the preferred rifamycin in HIV patients on protease-inhibitor or integrase-inhibitor regimens (rifampin is too strong an inducer for those regimens). It's a meaningful CYP3A4 inducer — about 40% as potent as rifampin — so it can lower ketamine plasma exposure during therapy. Patients may need higher KAP doses to achieve equivalent effect, or response may be muted. We evaluate case-by-case rather than refuse.
If you take Mycobutin regularly and are considering at-home ketamine therapy, eligibility depends on your specific situation — we evaluate case by case. This page covers the brief pharmacologic context and what we do at intake.
How Mycobutin interacts with ketamine
Rifabutin inhibits mycobacterial RNA polymerase. Moderate CYP3A4 induction (intermediate between rifampin's strong induction and rifaximin's near-zero systemic effect). Effect persists 1-2 weeks after the last dose.
What we do at intake
Disclose dose, indication, and any concurrent HIV medications. We may adjust the KAP dose upward or delay starting until at least 2 weeks after the course finishes.
Bottom line
Rifabutin alongside ketamine requires individual evaluation. Rifabutin is the preferred rifamycin in HIV patients on protease-inhibitor or integrase-inhibitor regimens (rifampin is too strong an inducer for those regimens). It's a meaningful CYP3A4 inducer — about 40% as potent as rifampin — so it can lower ketamine plasma exposure during therapy. Patients may need higher KAP doses to achieve equivalent effect, or response may be muted. We evaluate case-by-case rather than refuse.
Ready to find out if at-home ketamine fits your situation?
We’ll note that you’re on Mycobutin (Rifabutin) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.
FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.
Sources
The verdict and clinical guidance on this page are based on the following peer-reviewed literature and FDA prescribing information.
- Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthetic and Pain Therapy. Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI. Clinical Pharmacokinetics. 2016. PMID: 27028535
Clinically reviewed
Reviewed by Benjamin Soffer, DO on May 22, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.
This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.